NC
ANAB icon

Nexthera Capital’s AnaptysBio ANAB Stock Holding History

Nexthera Capital’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$679K Buy
+12,026
New +$866K 0.57% 22

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nexthera Capital's ANAB Position: Q2 2019 in Review

Nexthera Capital opened a new position in AnaptysBio (ANAB) in Q2 2019: 12,026 shares worth $679K. The stake represents 0.57% of the portfolio and ranks #22 among its holdings.

127 funds tracked by Wall St. Rank hold ANAB as of Q2 2019.

  • Nexthera Capital held 12,026 shares of AnaptysBio worth $679K as of Q2 2019.
  • AnaptysBio was a new Nexthera Capital position in Q2 2019.
  • AnaptysBio made up 0.57% of Nexthera Capital's portfolio in Q2 2019, its #22 holding.
  • 127 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2019.

Based on Nexthera Capital's 13F filing for Q2 2019, filed 14 Aug 2019.